Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Estimating the Impact and Cost of the WHO 2010 Recommendations for Antiretroviral Therapy.

Stover J, Bollinger L, Avila C.

AIDS Res Treat. 2011;2011:738271. doi: 10.1155/2011/738271.

2.

The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative.

Diomandé FV, Bissagnéné E, Nkengasong JN, Maurice C, Monga B, Laga M, Nolan ML.

AIDS. 2003 Jul;17 Suppl 3:S87-93.

PMID:
14565614
3.

National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?

Beck EJ, Vitoria M, Mandalia S, Crowley S, Gilks CF, Souteyrand Y.

AIDS. 2006 Jul 13;20(11):1497-502.

PMID:
16847404
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
5.

Changes in antiretroviral therapy guidelines: implications for public health policy and public purses.

Hamilton A, Garcia-Calleja JM, Vitoria M, Gilks C, Souteyrand Y, De Cock K, Crowley S.

Sex Transm Infect. 2010 Oct;86(5):388-90. doi: 10.1136/sti.2010.043018.

PMID:
20876757
6.

One world, one hope: the cost of providing antiretroviral therapy to all nations.

Hogg RS, Weber AE, Craib KJ, Anis AH, O'Shaughnessy MV, Schechter MT, Montaner JS.

AIDS. 1998 Nov 12;12(16):2203-9.

PMID:
9833862
7.
8.

Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, Tibouti A, Johns B, Hutubessy R, Salama P, Okwo-Bele JM.

Bull World Health Organ. 2008 Jan;86(1):27-39.

9.

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.

Sungkanuparph S, Anekthananon T, Hiransuthikul N, Bowonwatanuwong C, Supparatpinyo K, Mootsikapun P, Chetchotisakd P, Kiertiburanakul S, Tansuphaswadikul S, Buppanharun W, Manosuthi W, Techasathit W, Ratanasuwan W, Tantisiriwat W, Suwanagool S, Leechawengwongs M, Ruxrungtham K; Thai AIDS Society..

J Med Assoc Thai. 2008 Dec;91(12):1925-35.

PMID:
19133532
10.

API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.

Gupta SB, Pujari SN, Joshi SR, Patel AK; AIDS Society of India Guidelines Development Committee..

J Assoc Physicians India. 2006 Jan;54:57-74. Review.

PMID:
16649742
11.

Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.

Krentz HB, Gill MJ.

HIV Med. 2008 Oct;9(9):721-30. doi: 10.1111/j.1468-1293.2008.00613.x.

12.

Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility.

Callens SF, Kitetele F, Lusiama J, Shabani N, Edidi S, Colebunders R, Behets F, Van Rie A.

BMC Infect Dis. 2008 Mar 6;8:31. doi: 10.1186/1471-2334-8-31.

13.

Assessing efficiency and costs of scaling up HIV treatment.

Cleary SM, McIntyre D, Boulle AM.

AIDS. 2008 Jul;22 Suppl 1:S35-42. doi: 10.1097/01.aids.0000327621.24232.71.

PMID:
18664951
14.

The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.

Bishai D, Colchero A, Durack DT.

AIDS. 2007 Jun 19;21(10):1333-40.

PMID:
17545710
15.

Current and future antiretroviral treatment options in paediatric HIV infection.

Giaquinto C, Morelli E, Fregonese F, Rampon O, Penazzato M, de Rossi A, D'Elia R.

Clin Drug Investig. 2008;28(6):375-97. Review.

PMID:
18479179
16.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV..

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
17.

[Laboratory testing including CD4 T-cell count and determination of viral load to evaluate the impact of first line antiretroviral treatment at 6 months in adults in Benin].

Ogouyemi-Hounto A, Zannou D, Metodakou D, Lafia B, Gomez V, Akinocho E.

Med Trop (Mars). 2010 Feb;70(1):100. French.

PMID:
20337131
18.

Family income and the impact of a children's health insurance program on reported need for health services and unmet health need.

Feinberg E, Swartz K, Zaslavsky A, Gardner J, Walker DK.

Pediatrics. 2002 Feb;109(2):E29.

PMID:
11826239
19.

Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

Palombi L, Marazzi MC, Guidotti G, Germano P, Buonomo E, Scarcella P, Doro Altan A, Zimba Ida V, San Lio MM, De Luca A; DREAM Program..

Clin Infect Dis. 2009 Jan 1;48(1):115-122.

20.

HIV antiretroviral treatment: early versus later.

Mauskopf J, Kitahata M, Kauf T, Richter A, Tolson J.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):562-9.

PMID:
16044008
Items per page

Supplemental Content

Support Center